-+ 0.00%
-+ 0.00%
-+ 0.00%

Pyxis Oncology Q4 EPS $(0.29) Beats $(0.33) Estimate, Sales $11.038M

Benzinga·03/23/2026 11:12:53
Listen to the news
Pyxis Oncology (NASDAQ:PYXS) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.33) by 12.65 percent. This is a 50.85 percent increase over losses of $(0.59) per share from the same period last year. The company reported $11.038 million in sales this quarter.